Sorry, you need to enable JavaScript to visit this website.

Board Changes January 2021

| Filed in:

30 December 2020: Tate & Lyle PLC (the “Company”) announces that John Cheung will join the Board as a non-executive director and a member of the Audit and Nominations Committees on 1 January 2021.

John Cheung headshot tile
John Cheung

Currently an executive director of nutrition group China Feihe Limited, John brings a breadth of food and beverage experience with a deep understanding of markets in Asia, particularly in China. In a career spanning 30 years in the fields of nutrition, food and beverages, John has served as President for Wyeth Nutrition Global, having previously served as Nestlé Group’s leader in China and earlier held senior roles with Coca-Cola and Procter & Gamble.

After nearly nine years on the Board, the Company also announces that non-executive director, Dr Ajai Puri, will retire on 31st March 2021.

Dr Gerry Murphy, Chairman of Tate & Lyle, said: “I am delighted that John has agreed to join the Board. His appointment recognises the importance of the Asia Pacific region to Tate & Lyle’s growth and development. His substantial experience in the Chinese and broader Asian food and beverage industry will be of significant benefit to the Board.

"I also thank Dr Puri for his nine years of dedicated service and significant contribution to the Board and, in particular, for his time as Chairman of our Research Advisory Group. Ajai’s wisdom, technological insights and management experience have been exceptionally valuable as Tate & Lyle has evolved into a global, science-led food ingredient business.”

There are no further disclosures to be made in connection with Mr Cheung’s appointment pursuant to paragraph 9.6.13 of the Financial Conduct Authority’s Listing Rules.

END

For more information contact

Nick Hasell, FTI Consulting (Media)
Tel: Mobile: +44 (0) 7825 523 383

Christopher Marsh, VP, Investor Relations
[email protected] / +44 (0) 7796 192 688

Click here for our press image gallery

About Tate & Lyle: 
Tate & Lyle is a world leader in ingredient solutions for healthier food and beverages. Supported by our 160-year history of ingredient innovation, we partner with customers to provide consumers with healthier and tastier choices when they eat and drink. We are proud that millions of people around the world consume products containing our ingredients every day.

Through our expertise in sweetening, mouthfeel and fortification, we develop solutions which reduce sugar, calories and fat, add fibre and protein, and provide texture and stability in categories including beverages, dairy, bakery, soups, sauces and dressings.

We have more than 3,500 employees working in around 60 locations across 39 countries. Tate & Lyle's purpose is Transforming Lives Through the Science of Food and through our purpose we believe we can successfully grow our business and have a positive impact on society. We live our purpose in three ways, by supporting healthy living, building thriving communities and caring for our planet.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2022, Tate & Lyle revenue from continuing operations totalled £1.4 billion. For more information, please visit https://www.tateandlyle.com or follow Tate & Lyle on TwitterLinkedin or Facebook.